Promises and Pitfalls of ctDNA testing in the Management of Cholangiocarcinoma.

Liu M, Doger B, Pant A, Lamarca A, Goyal L

Open source

DOI
10.1016/j.jhepr.2026.102023
Published
2026 Sep 17
Container
JHEP reports : innovation in hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jhepr.2026.102023,
  title = {Promises and Pitfalls of ctDNA testing in the Management of Cholangiocarcinoma.},
  author = {Liu M and Doger B and Pant A and Lamarca A and Goyal L},
  year = {2026},
  journal = {JHEP reports : innovation in hepatology},
  doi = {10.1016/j.jhepr.2026.102023},
  url = {https://doi.org/10.1016/j.jhepr.2026.102023}
}

RIS

TY  - JOUR
TI  - Promises and Pitfalls of ctDNA testing in the Management of Cholangiocarcinoma.
AU  - Liu M
AU  - Doger B
AU  - Pant A
AU  - Lamarca A
AU  - Goyal L
PY  - 2026
JO  - JHEP reports : innovation in hepatology
DO  - 10.1016/j.jhepr.2026.102023
UR  - https://doi.org/10.1016/j.jhepr.2026.102023
ER  - 

APA

M, L., B, D., A, P., A, L., & L, G. (2026). Promises and Pitfalls of ctDNA testing in the Management of Cholangiocarcinoma.. JHEP reports : innovation in hepatology. https://doi.org/10.1016/j.jhepr.2026.102023

Source records